NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

They know that LP will continue to dilute in pennies in 2026 as well as raise authorized share count regardless of the timing and outcome of UK decision. They know that revenues will be extremely disappointing whether it comes from Specials or after approval (without reimbursement).

They also know that excuses and victim mindset won’t stop in 2026, 2027, and beyond. So it’s an easy sell!